Peers & Perspectives in Oncology
December I 2025
November 2025
October 2025
September I 2025
September II 2025
August 2025
July 2025
June I 2025
Volume: 3
June II 2025
May 2025
April 2025
March I 2025
March II 2025
February 2025
January 2025
Volume: 03
Issue: 01
December I, 2024
December II, 2024
November 2024
October II 2024
October I 2024
September 2024
August I, 2024
August II, 2024
Volume: 2
Issue: 12
July 2024
June II, 2024
June I 2024
May 2024
Volume: 2
Issue: 7
April II, 2024
April I, 2024
March 2024
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Gedatolisib Improves PFS in HR+/HER2-/PIK3CA-WT Advanced Breast Cancer
2
Nadunolimab Misses Efficacy Mark in TNBC, Despite Strong OS
3
FDA Approves Niraparib/Abiraterone Combo for BRCA2-Mutated mCSPC
4
Giredestrant/Everolimus Improves PFS Across Subgroups After CDK4/6i in ER+/HER2– Breast Cancer
5
